Cargando…
Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway
Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043408/ https://www.ncbi.nlm.nih.gov/pubmed/29643476 http://dx.doi.org/10.1038/s41388-018-0241-0 |
_version_ | 1783339278345961472 |
---|---|
author | Yu, Yu Rahmanto, Yohan Suryo Lee, Meng-Horng Wu, Pei-Hsun Phillip, Jude M. Huang, Chuan-Hsiang Vitolo, Michele I. Gaillard, Stephanie Martin, Stuart S. Wirtz, Denis Shih, Ie-Ming Wang, Tian-Li |
author_facet | Yu, Yu Rahmanto, Yohan Suryo Lee, Meng-Horng Wu, Pei-Hsun Phillip, Jude M. Huang, Chuan-Hsiang Vitolo, Michele I. Gaillard, Stephanie Martin, Stuart S. Wirtz, Denis Shih, Ie-Ming Wang, Tian-Li |
author_sort | Yu, Yu |
collection | PubMed |
description | Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombinant SYK directly phosphorylates cortactin and cofilin, which are critically involved in assembly and dynamics of actin filament through phosphorylation signaling. Enhancing SYK activity by inducing expression of a constitutively active SYK mutant, SYK(130E), increased growth factor-stimulated migration and invasion of ovarian cancer cells, which was abrogated by cortactin knockdown. Similarly, SYK inhibitors significantly decreased invasion of ovarian cancer cells through basement membrane matrix in a real-time transwell assays and in a 3-D tumor spheroid model. SYK inactivation by gene knockout or by small molecule inhibition reduced actin polymerization. Collectively, the results reported here identify a new mechanism by which SYK signaling regulates ovarian cancer cell motility and invasiveness, and pinpoint a target-based strategy to prevent or suppress the advancement of ovarian malignancies. |
format | Online Article Text |
id | pubmed-6043408 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
record_format | MEDLINE/PubMed |
spelling | pubmed-60434082018-10-11 Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway Yu, Yu Rahmanto, Yohan Suryo Lee, Meng-Horng Wu, Pei-Hsun Phillip, Jude M. Huang, Chuan-Hsiang Vitolo, Michele I. Gaillard, Stephanie Martin, Stuart S. Wirtz, Denis Shih, Ie-Ming Wang, Tian-Li Oncogene Article Ovarian cancer cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly associated with tumor progression in ovarian cancer. Here, we report that active recombinant SYK directly phosphorylates cortactin and cofilin, which are critically involved in assembly and dynamics of actin filament through phosphorylation signaling. Enhancing SYK activity by inducing expression of a constitutively active SYK mutant, SYK(130E), increased growth factor-stimulated migration and invasion of ovarian cancer cells, which was abrogated by cortactin knockdown. Similarly, SYK inhibitors significantly decreased invasion of ovarian cancer cells through basement membrane matrix in a real-time transwell assays and in a 3-D tumor spheroid model. SYK inactivation by gene knockout or by small molecule inhibition reduced actin polymerization. Collectively, the results reported here identify a new mechanism by which SYK signaling regulates ovarian cancer cell motility and invasiveness, and pinpoint a target-based strategy to prevent or suppress the advancement of ovarian malignancies. 2018-04-11 2018-07 /pmc/articles/PMC6043408/ /pubmed/29643476 http://dx.doi.org/10.1038/s41388-018-0241-0 Text en Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Yu, Yu Rahmanto, Yohan Suryo Lee, Meng-Horng Wu, Pei-Hsun Phillip, Jude M. Huang, Chuan-Hsiang Vitolo, Michele I. Gaillard, Stephanie Martin, Stuart S. Wirtz, Denis Shih, Ie-Ming Wang, Tian-Li Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title | Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title_full | Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title_fullStr | Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title_full_unstemmed | Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title_short | Inhibition of ovarian tumor cell invasiveness by targeting SYK in tyrosine kinase signaling pathway |
title_sort | inhibition of ovarian tumor cell invasiveness by targeting syk in tyrosine kinase signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043408/ https://www.ncbi.nlm.nih.gov/pubmed/29643476 http://dx.doi.org/10.1038/s41388-018-0241-0 |
work_keys_str_mv | AT yuyu inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT rahmantoyohansuryo inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT leemenghorng inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT wupeihsun inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT phillipjudem inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT huangchuanhsiang inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT vitolomichelei inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT gaillardstephanie inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT martinstuarts inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT wirtzdenis inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT shihieming inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway AT wangtianli inhibitionofovariantumorcellinvasivenessbytargetingsykintyrosinekinasesignalingpathway |